Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00069836
Status:
COMPLETED
Last Update Posted:
2016-09-01
First Post:
2003-10-01
Brief Title:
Study Of AVANDAMET With Or Without Insulin In Type II Diabetes Mellitus Patients AVANDAMET is a Registered Trademark of the GSK Group of Companies
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
A 24 Week Randomised Double Blind Parallel Study to Compare the Change in HbA1c With AVANDAMET 80mg 20g Plus Insulin to Placebo Plus Insulin in Subjects With Type 2 Diabetes Starting Insulin Therapy
Status:
COMPLETED
Status Verified Date:
2016-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study was designed to test the safety and efficacy how well it works of AVANDAMET in combination with insulin in improving the control of blood sugar when compared with taking insulin on its own AVANDAMET capsules contain a fixed dose of AVANDIA and metformin Both AVANDIA and metformin are medicines which are individually licensed for the treatment of type II diabetes mellitus Because they act in different ways it is thought that combining them may give an increased benefit of treating diabetes and reducing blood sugar
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None